Intravenous sildenafil as an effective treatment of pulmonary hypertensive crises during acute intestinal malabsorption

Cardiology in the Young

Volumn 16, Issue 1, 2006, Pages 84-86

  Lammers, Astrid E ^a   Haworth, Sheila G ^a   Pierce, Christine M ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Children; Pulmonary hypertension; Pulmonary vasodilator

Indexed keywords

NITRIC OXIDE; OXYGEN; SILDENAFIL;

ACUTE DISEASE; ACUTE RESPIRATORY FAILURE; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL PROTOCOL; DRUG EFFICACY; ECHOCARDIOGRAPHY; EXTUBATION; FOLLOW UP; HUMAN; INFANT; INTENSIVE CARE; MALABSORPTION; MALE; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PULMONARY HYPERTENSION; RECURRENT DISEASE;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ACUTE DISEASE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFUSIONS, INTRAVENOUS; MALABSORPTION SYNDROMES; MALE; PIPERAZINES; VASODILATOR AGENTS;

EID: 32144464958     PISSN: 10479511     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1047951105002155     Document Type: Article

References (10)

1. Ghofrani HA, Wiedemann R, Rose F, et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: A randomized controlled trial. Lancet 2002; 360: 895-900.
2. Prasad S, Wilkinson J, Gatzoulis MA. Sildenafil in primary pulmonary hypertension. N Eng J Med 2000; 343: 1342.
3. Sastry BK, Narasimhan C, Reddy NK, Raju BS. Clinical efficacy of Sildenafil in primary pulmonary hypertension: A randomized, placebo controlled, double blind, cross over study. J Am Coll Cardiol 2004; 43: 1149.
4. Stiebellehner L, Petkov V, Vonbank K et al. Long-term treatment with oral Sildenafil in addition to continuous iv Epoprostenol in patients with pulmonary arterial hypertension. Chest 2003; 123: 1293-1295.
5. Leuchte HH, Schwaiblmair M, Baumgartner RA, Neurohr CF, Kolbe T, Behr J. Hemodynamic response to Sildenafl, nitric oxide, and Iloprost in primary pulmonary hypertension. Chest 2004; 125: 580-586.
6. Rabe KF, Tenor H, Dent G, Schudt C, Nakashima M, Magnussen H. Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. Am J Physiol 1994; 266: L536-L543.
7. Abrams D, Schulze-Neick I, Magee AG. Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 2000; 84: E4.
8. Sherkerdemian LS, Ravn HB, Penny DJ. Intravenous Sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Resp Crit Care Med 2002; 165: 1098-1102.
9. Schulze-Neick I, Hartenstein P, Li J et al. Intravenous Sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation 2003; 108 (Suppl III): II-167-II-173.
10. Stocker C, Penny DJ, Brizard CP, Cochrane AD, Soto R, Sherkerdemian LS. Intravenous Sildenafil and inhaled nitric oxide: A randomized trial in infants after cardiac surgery. Intensive Care Med 2003; 29: 1996-2003.